Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support

Giovanni Ambrosino, Sergio Varotto, M. M Stefano Basso, Daniele Galavotti, Attilio Cecchetto, Paolo Carraro, Agostino Naso, Giustina De Silvestro, Mario Plebani, Gianpiero Giron, Giovanni Abatangelo, Daniele Donato, Adriano Cestrone, Luigi Marrelli, Marcella Trombetta, Vincenzo Lorenzelli, Antonio Picardi, Alessandra Colantoni, David Van Thiel, Camillo Ricordi & 1 others Francesco Davide D'Amico

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Long-term maintenance of hepatocyte viability and differentiated function expression is crucial for bioartificial liver support. The maintenance of hepatocyte function in a bioreactor is still a problem. A major advance was the recognition that hepatocytes in attachment cultures can maintain their differentiation longer. To restore hepatocyte polarity and prolong their function, we developed a new bioreactor with a crossflow geometry configuration and an original hepatocyte extracellular autologous biomatrix (Porcine Bio-Matrix) support. To test this new bioreactor, we compared it with a standard bioartificial liver cartridge in a suitable surgical model of acute liver failure in pigs. In our model, we performed a total hepatectomy, followed by partial liver transplantation after an 18 hour anhepatic phase. The results showed that the bioreactor containing the biomatrix was able to bridge the animal to transplantation and to sustain the transplanted liver until all function recovered (80% of animals survived, p = 0.0027). No animal survived more than 24 hours after liver transplantation in the group treated with the traditional bioartificial liver, whereas hepatocyte viability on the Porcine Bio-Matrix was 65% after 12 hours of treatment. The results suggest that our biomatrix is a suitable cell support and guarantees long-term maintenance of metabolic activity of hepatocytes. Further studies are needed, but the results obtained with this new three-dimensional bioreactor are promising, and its potential is attractive.

Original languageEnglish
Pages (from-to)592-597
Number of pages6
JournalASAIO Journal
Volume48
Issue number6
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

Artificial Liver
Liver
Hepatocytes
Swine
Bioreactors
Animals
Liver Transplantation
Anatomic Models
Acute Liver Failure
Hepatectomy
Transplantation
Maintenance
Geometry

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Ambrosino, G., Varotto, S., Basso, M. M. S., Galavotti, D., Cecchetto, A., Carraro, P., ... D'Amico, F. D. (2002). Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support. ASAIO Journal, 48(6), 592-597.

Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support. / Ambrosino, Giovanni; Varotto, Sergio; Basso, M. M Stefano; Galavotti, Daniele; Cecchetto, Attilio; Carraro, Paolo; Naso, Agostino; De Silvestro, Giustina; Plebani, Mario; Giron, Gianpiero; Abatangelo, Giovanni; Donato, Daniele; Cestrone, Adriano; Marrelli, Luigi; Trombetta, Marcella; Lorenzelli, Vincenzo; Picardi, Antonio; Colantoni, Alessandra; Van Thiel, David; Ricordi, Camillo; D'Amico, Francesco Davide.

In: ASAIO Journal, Vol. 48, No. 6, 01.11.2002, p. 592-597.

Research output: Contribution to journalArticle

Ambrosino, G, Varotto, S, Basso, MMS, Galavotti, D, Cecchetto, A, Carraro, P, Naso, A, De Silvestro, G, Plebani, M, Giron, G, Abatangelo, G, Donato, D, Cestrone, A, Marrelli, L, Trombetta, M, Lorenzelli, V, Picardi, A, Colantoni, A, Van Thiel, D, Ricordi, C & D'Amico, FD 2002, 'Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support', ASAIO Journal, vol. 48, no. 6, pp. 592-597.
Ambrosino G, Varotto S, Basso MMS, Galavotti D, Cecchetto A, Carraro P et al. Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support. ASAIO Journal. 2002 Nov 1;48(6):592-597.
Ambrosino, Giovanni ; Varotto, Sergio ; Basso, M. M Stefano ; Galavotti, Daniele ; Cecchetto, Attilio ; Carraro, Paolo ; Naso, Agostino ; De Silvestro, Giustina ; Plebani, Mario ; Giron, Gianpiero ; Abatangelo, Giovanni ; Donato, Daniele ; Cestrone, Adriano ; Marrelli, Luigi ; Trombetta, Marcella ; Lorenzelli, Vincenzo ; Picardi, Antonio ; Colantoni, Alessandra ; Van Thiel, David ; Ricordi, Camillo ; D'Amico, Francesco Davide. / Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support. In: ASAIO Journal. 2002 ; Vol. 48, No. 6. pp. 592-597.
@article{5fa31233456743608fbe263053161f6c,
title = "Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support",
abstract = "Long-term maintenance of hepatocyte viability and differentiated function expression is crucial for bioartificial liver support. The maintenance of hepatocyte function in a bioreactor is still a problem. A major advance was the recognition that hepatocytes in attachment cultures can maintain their differentiation longer. To restore hepatocyte polarity and prolong their function, we developed a new bioreactor with a crossflow geometry configuration and an original hepatocyte extracellular autologous biomatrix (Porcine Bio-Matrix) support. To test this new bioreactor, we compared it with a standard bioartificial liver cartridge in a suitable surgical model of acute liver failure in pigs. In our model, we performed a total hepatectomy, followed by partial liver transplantation after an 18 hour anhepatic phase. The results showed that the bioreactor containing the biomatrix was able to bridge the animal to transplantation and to sustain the transplanted liver until all function recovered (80{\%} of animals survived, p = 0.0027). No animal survived more than 24 hours after liver transplantation in the group treated with the traditional bioartificial liver, whereas hepatocyte viability on the Porcine Bio-Matrix was 65{\%} after 12 hours of treatment. The results suggest that our biomatrix is a suitable cell support and guarantees long-term maintenance of metabolic activity of hepatocytes. Further studies are needed, but the results obtained with this new three-dimensional bioreactor are promising, and its potential is attractive.",
author = "Giovanni Ambrosino and Sergio Varotto and Basso, {M. M Stefano} and Daniele Galavotti and Attilio Cecchetto and Paolo Carraro and Agostino Naso and {De Silvestro}, Giustina and Mario Plebani and Gianpiero Giron and Giovanni Abatangelo and Daniele Donato and Adriano Cestrone and Luigi Marrelli and Marcella Trombetta and Vincenzo Lorenzelli and Antonio Picardi and Alessandra Colantoni and {Van Thiel}, David and Camillo Ricordi and D'Amico, {Francesco Davide}",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "48",
pages = "592--597",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support

AU - Ambrosino, Giovanni

AU - Varotto, Sergio

AU - Basso, M. M Stefano

AU - Galavotti, Daniele

AU - Cecchetto, Attilio

AU - Carraro, Paolo

AU - Naso, Agostino

AU - De Silvestro, Giustina

AU - Plebani, Mario

AU - Giron, Gianpiero

AU - Abatangelo, Giovanni

AU - Donato, Daniele

AU - Cestrone, Adriano

AU - Marrelli, Luigi

AU - Trombetta, Marcella

AU - Lorenzelli, Vincenzo

AU - Picardi, Antonio

AU - Colantoni, Alessandra

AU - Van Thiel, David

AU - Ricordi, Camillo

AU - D'Amico, Francesco Davide

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Long-term maintenance of hepatocyte viability and differentiated function expression is crucial for bioartificial liver support. The maintenance of hepatocyte function in a bioreactor is still a problem. A major advance was the recognition that hepatocytes in attachment cultures can maintain their differentiation longer. To restore hepatocyte polarity and prolong their function, we developed a new bioreactor with a crossflow geometry configuration and an original hepatocyte extracellular autologous biomatrix (Porcine Bio-Matrix) support. To test this new bioreactor, we compared it with a standard bioartificial liver cartridge in a suitable surgical model of acute liver failure in pigs. In our model, we performed a total hepatectomy, followed by partial liver transplantation after an 18 hour anhepatic phase. The results showed that the bioreactor containing the biomatrix was able to bridge the animal to transplantation and to sustain the transplanted liver until all function recovered (80% of animals survived, p = 0.0027). No animal survived more than 24 hours after liver transplantation in the group treated with the traditional bioartificial liver, whereas hepatocyte viability on the Porcine Bio-Matrix was 65% after 12 hours of treatment. The results suggest that our biomatrix is a suitable cell support and guarantees long-term maintenance of metabolic activity of hepatocytes. Further studies are needed, but the results obtained with this new three-dimensional bioreactor are promising, and its potential is attractive.

AB - Long-term maintenance of hepatocyte viability and differentiated function expression is crucial for bioartificial liver support. The maintenance of hepatocyte function in a bioreactor is still a problem. A major advance was the recognition that hepatocytes in attachment cultures can maintain their differentiation longer. To restore hepatocyte polarity and prolong their function, we developed a new bioreactor with a crossflow geometry configuration and an original hepatocyte extracellular autologous biomatrix (Porcine Bio-Matrix) support. To test this new bioreactor, we compared it with a standard bioartificial liver cartridge in a suitable surgical model of acute liver failure in pigs. In our model, we performed a total hepatectomy, followed by partial liver transplantation after an 18 hour anhepatic phase. The results showed that the bioreactor containing the biomatrix was able to bridge the animal to transplantation and to sustain the transplanted liver until all function recovered (80% of animals survived, p = 0.0027). No animal survived more than 24 hours after liver transplantation in the group treated with the traditional bioartificial liver, whereas hepatocyte viability on the Porcine Bio-Matrix was 65% after 12 hours of treatment. The results suggest that our biomatrix is a suitable cell support and guarantees long-term maintenance of metabolic activity of hepatocytes. Further studies are needed, but the results obtained with this new three-dimensional bioreactor are promising, and its potential is attractive.

UR - http://www.scopus.com/inward/record.url?scp=0036841421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036841421&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 592

EP - 597

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 6

ER -